Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The Abramson Cancer Center at the University of Pennsylvania, The Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, and The Tisch Cancer Institute at the ...
read more
Framework Solutions announced the appointment of Russ Belden as Head of Commercial Solutions, effective April 26th, 2023.
read more
Tuesday, December 06, 2022
Fraunhofer IZI, one of Europe’s leading manufacturers of cell and gene therapies for clinical trials, intends to digitalize its manufacturing operations with MODA-ES®, the Manufacturing Execution System from Lonza. Fraunhofer IZI will use Lonza’s ...
read more
Implementing the optimum strategy for patient randomization and drug management though the use of interactive response technology can greatly reduce waste and improve efficiency in blinded clinical trials. However, IRT can increase the risks of ...
read more
Biochemists Emmanuelle Charpentier from France and Jennifer Doudna from the United States have been awarded Spain's Princess of Asturias scientific research award for their work in biotechnology.
read more
Frenova Renal Research, a drug and medical device contract clinical development services provider dedicated to renal research, has announced the opening of a new office location in downtown Durham, N.C., and the expansion of its U.S. field-based ...
read more
Frenova Renal Research has added an additional location to its roster of managed clinical research sites.
read more
Frenova Renal Research announced that its F1RST Up alliance of clinical research sites focusing on kidney disease has expanded to include 55 physician investigators representing 23 sites.
read more
Wednesday, October 06, 2021
Fresenius Kabi and Health Care Logistics®, Inc. (HCL) today announced a collaboration designed to make drug replenishment in hospitals more efficient and improve patient safety throughout the medication-use process. The new collaboration allows ...
read more
Fresenius Kabi is voluntarily recalling two lots of Fluorouracil Injection, USP 5g/100mL (50mg/mL), 100mL fill in 100mL vials, to the user level due to the potential for glass particulate.
read more
Monday, December 07, 2020
Fresenius Kabi USA is voluntarily recalling a single lot of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg /mL), 50 mL fill in a 50 mL vial.
read more
Fresenius Kabi USA is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg / mL), 50 mL fill in a 50 mL vial.
read more
Monday, December 03, 2018
Fresenius Kabi has received a Drug Shortage Assistance Award from the U.S. Food and Drug Administration (FDA).
read more
Wednesday, April 26, 2017
Fresenius Kabi will acquire Akorn, a U.S.-based manufacturer and marketer of prescription and over-the-counter pharmaceutical products, for approximately $4.3 billion, or $34.00 a share, plus the assumption of approximately $450 million of debt.
read more
Kabi, a leading provider of infusion therapy and clinical nutrition, and Fenwal Inc. a global leader specializing in separation technologies for blood and cell collection and therapy, announced today a definitive agreement for Fresenius Kabi to ...
read more